Schedule 13G ownership disclosure

REVOLUTION MEDICINES INC COM

Security class unavailable · CUSIP: 76155X100

Event date: 2023-10-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
14,219,430
Percent of class
12.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-23-000050
Form type
SC 13G/A
Filer
Revolution Medicines, Inc.
CIK
CIK 1628171
Filed
Nov 09, 2023
Reporting period
Oct 31, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub